A comparison of medication access services at 340B and non-340B hospitals
2021 · Research in Social and Administrative Pharmacy · 15 citations
https://doi.org/10.1016/j.sapharm.2021.03.010
N
Nadia Nabulsi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
209
Citations
9
h-index
9
i10-index
Nadia Nabulsi is an academic researcher from AbbVie (United States). The author has contributed to research in topics: Multiple and Secondary Primary Cancers & Treatment of Major Depression & Frailty in Older Adults. The author has an h-index of 9, co-authored 36 publications.
ORCID: 0000-0003-0632-6311Papers by this author
worksPopulation-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race
2021 · The Breast · 12 citations
https://doi.org/10.1016/j.breast.2021.08.005
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis
2024 · Advances in Therapy · 11 citations
https://doi.org/10.1007/s12325-024-02817-w
Physical functioning, frailty and risks of locally-advanced breast cancer among older women
2022 · The Breast · 5 citations
https://doi.org/10.1016/j.breast.2022.04.005
Real-world effectiveness of cariprazine in major depressive disorder and bipolar I disorder in the United States
2025 · Journal of Medical Economics · 5 citations
https://doi.org/10.1080/13696998.2025.2513766
Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer
2022 · Cancer Causes & Control · 4 citations
https://doi.org/10.1007/s10552-022-01561-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat